U.S. gives up to $1.2 billion to AstraZeneca for Covid-19 vaccine

The race over funding and access to a Covid-19 vaccine is heating up as the U.S. government pledged to commit up to $1.2 billion to AstraZeneca (AZN) for its efforts and obtain at least 300 million doses of any vaccine by October. And as part of the deal with the Biomedical Advanced Research and Development Authority, the drug maker will begin late-stage clinical trials this summer with roughly 30,000 people in the U.S.

In a statement, Health and Human Services Secretary Alex Azar called the contract a “major milestone” in Operation Warp Speed, a newly launched Trump administration program to

Leave a Reply